R01MH120594
Project Grant
Overview
Grant Description
Early-phase schizophrenia: Practice-based research to improve treatment outcomes (ESPRITO)
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 373% from $1,620,699 to $7,660,197.
The Feinstein Institutes For Medical Research was awarded
Project Grant R01MH120594
worth $7,660,197
from the National Institute of Mental Health in August 2019 with work to be completed primarily in New York United States.
The grant
has a duration of 4 years 9 months and
was awarded through assistance program 93.242 Mental Health Research Grants.
The Project Grant was awarded through grant opportunity Early Psychosis Intervention Network (EPINET): Practice-Based Research to Improve Treatment Outcomes (R01 Clinical Trial Optional).
Status
(Complete)
Last Modified 7/20/23
Period of Performance
8/22/19
Start Date
5/31/24
End Date
Funding Split
$7.7M
Federal Obligation
$0.0
Non-Federal Obligation
$7.7M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for R01MH120594
Transaction History
Modifications to R01MH120594
Additional Detail
Award ID FAIN
R01MH120594
SAI Number
R01MH120594-3282089938
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75N700 NIH NATIONAL INSTITUTE OF MENTAL HEALTH
Funding Office
75N700 NIH NATIONAL INSTITUTE OF MENTAL HEALTH
Awardee UEI
C5LHMPRJ9J19
Awardee CAGE
3D9G5
Performance District
NY-03
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute of Mental Health, National Institutes of Health, Health and Human Services (075-0892) | Health research and training | Grants, subsidies, and contributions (41.0) | $7,881,597 | 100% |
Modified: 7/20/23